• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. - CRM FACILITY PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. - CRM FACILITY PLATINIUM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION Back to Search Results
Model Number PLATINIUM SONR CRT-D 1841
Device Problems Over-Sensing (1438); Pacing Problem (1439)
Patient Problem No Information (3190)
Event Date 11/27/2019
Event Type  malfunction  
Manufacturer Narrative
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by sorin that was cleared or approved by fda for marketing in the united states.
 
Event Description
Reportedly, the subject crt-d was implanted on (b)(6) 2019.The physician reported several episodes of ventricular tachycardia and ventricular fibrillation and one shock during review of the remote follow-up transmitted on (b)(6) 2019 and during the in-clinic follow-up performed on (b)(6) 2019.Sensing of the atrial signals in the ventricular channel was observed since the end of (b)(6) and beginning of (b)(6) when the patient was in atrial fibrillation.Non efficient ventricular pacing was also reported, as well as a decrease of the ventricular lead impedance.During a re-intervention performed on (b)(6) 2019, loose right ventricular lead was reportedly observed on x-ray images, but it remained inside the right ventricle.The right ventricular lead was re-implanted in the apex and a new ventricular lead was implanted in the outflow tract.Preliminary analysis results confirmed the reported behaviors.They most probably resulted from a right ventricular lead positioning issue.
 
Manufacturer Narrative
The description of the events contained a mistake that has been corrected (field b5).
 
Event Description
Reportedly, the subject crt-d was implanted on (b)(6) 2019.The physician reported several episodes of ventricular tachycardia and ventricular fibrillation and one shock during review of the remote follow-up transmitted on (b)(6) 2019 and during the in-clinic follow-up performed on (b)(6) 2019.Sensing of the atrial signals in the ventricular channel was observed since the end of october and beginning of november when the patient was in atrial fibrillation.Non efficient ventricular pacing was also reported, as well as a decrease of the ventricular lead impedance.During a re-intervention performed on (b)(6) 2019, loose right ventricular lead was reportedly observed on x-ray images, but it remained inside the right ventricle.Thus, the right ventricular lead (that was implanted in the apex) was explanted and replaced by another one that was implanted in the outflow tract.Preliminary analysis results confirmed the reported behaviors.They most probably resulted from a right ventricular lead positioning issue.
 
Event Description
Reportedly, the subject crt-d was implanted on (b)(6) 2019.The physician reported several episodes of ventricular tachycardia and ventricular fibrillation and one shock during review of the remote follow-up transmitted on (b)(6) 2019 and during the in-clinic follow-up performed on (b)(6) 2019.Sensing of the atrial signals in the ventricular channel was observed since the end of (b)(6) and beginning of (b)(6) when the patient was in atrial fibrillation.Non efficient ventricular pacing was also reported, as well as a decrease of the ventricular lead impedance.During a re-intervention performed on (b)(6) 2019, loose right ventricular lead was reportedly observed on x-ray images, but it remained inside the right ventricle.Thus, the right ventricular lead (that was implanted in the apex) was explanted and replaced by another one that was implanted in the outflow tract.Preliminary analysis results confirmed the reported behaviors.They most probably resulted from a right ventricular lead positioning issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLATINIUM
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, CARDIAC RESYNCHRONIZATION
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR  92140
MDR Report Key9526745
MDR Text Key177565786
Report Number1000165971-2019-00744
Device Sequence Number1
Product Code NIK
UDI-Device Identifier08031527014425
UDI-Public(01)08031527014425(11)190109(17)200809
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 06/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/09/2020
Device Model NumberPLATINIUM SONR CRT-D 1841
Device Catalogue NumberPLATINIUM SONR CRT-D 1841
Device Lot NumberS0348
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/04/2019
Initial Date Manufacturer Received 12/04/2019
Initial Date FDA Received12/27/2019
Supplement Dates Manufacturer Received01/15/2020
06/08/2020
Supplement Dates FDA Received01/20/2020
06/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-